While data are limited regarding AEDs and breastfeeding, it appears that none of the AEDs are excreted at high levels into the breast milk, nor have they been associated with high rates of adverse events in the nursing infant.
The PLLR helps to put the potential effects of the drug into perspective with the goal of providing a more individualized risk-benefit analysis.
This review article provides clinically relevant data but also helps the reader navigate some of the more controversial issues in the field.
Lamotrigine is detected in the breast milk and in the serum of the nursing infant; however, the risk of adverse events is very low.
Because women with bipolar disorder are at high risk for relapse during the postpartum period, we typically recommend that women continue treatment with lithium throughout the postpartum period. While this intervention clearly decreases risk for postpartum psychiatric illness, the use of lithium while breastfeeding presents certain challenges.
Many women taking stimulants question whether it is safe to take these medications while breastfeeding.
A significant number of women consume cannabis while breastfeeding. What do we know about the effects of cannabis on the nursing infant?
Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]
Although new mothers describe breastfeeding as a meaningful and fulfilling aspect of caring for their infants, breastfeeding is also a common source of stress and anxiety. A recent study suggests that difficulties with breastfeeding may [...]
We frequently receive questions regarding the safety of drinking alcohol while breastfeeding. While the harmful effects of alcohol use during pregnancy are well known, we have much less information regarding the consequences of alcohol [...]
